Seasonal influenza and pneumococcal vaccination coverage among immunocompromised adults in France: A need for improvement - 24/12/25
Highlights |
• | We drew up an estimation of vaccine coverage in 10,784 immunocompromised adults in France. |
• | Complete pneumococcal and influenza vaccine coverage in 2011-2017was < 15 %. |
• | Influenza vaccine coverage correlated with age, ranging from 1.2 % (18–34 years) to 38.7 % (>65 years). |
• | Given the burden of these diseases in immunocompromised individuals, vaccine policies need to be strengthened. |
Abstract |
Objective |
To estimate influenza and pneumococcal vaccination coverage in immunocompromised adults in France.
Methods |
We used the Echantillon Généraliste des Bénéficiaires database, a representative sample of 850,000 patients covered by health insurance, with prospective collection of data on health care. We included adult patients with at least one of the following conditions: people living with HIV (PLWH), solid organ transplant, cancer treated by chemotherapy, any patient under immunosuppressive/immunomodulating therapy.
Results |
We enrolled 10,784 immunocompromised patients, with a median age of 49 years [35–63]. During 2011–2017, complete seasonal influenza vaccine coverage (i.e., one shot each year) was 14.3 % [13.6–15.0] and closely correlated with age: 1.2 %, 2.8 %, 10.9 %, and 38.7 %, in the age groups 18–34, 35–49, 50–65, and > 65 years, respectively ( P < 0.01). Pneumococcal vaccine coverage was complete (13-valent conjugated vaccine followed by 23-valent polysaccharide vaccine) in 6.9 %, not correlated with age.
Conclusions |
Influenza and pneumococcal vaccine coverage in France during the study period, was very low, complete in < 15 % of immunocompromised adults.
Le texte complet de cet article est disponible en PDF.Keywords : Immunocompromised, Vaccines, Streptococcus pneumoniae , Influenza, France
Plan
Vol 56 - N° 1
Article 105225- janvier 2026 Retour au numéro
Article précédent
- Epidemiology and outcomes of multidrug-resistant tuberculosis in Rwanda
- J. NTWARI, R. NDIAYE, L. MWISENEZA, Y. HABIMANA, E. SERUYANGE, O. SEBATUNZI, P. MIGAMBI, JP. RWABIHAMA, S. GALLIEN
- Prognosis of central venous catheter-related Candida infection during hospitalization in conventional medical or surgical wards: A 13-year retrospective cohort study
- Aida Zaghdoudi, Arthur Hacquin, Stéphane Valot, Mathieu Blot, Lionel Piroth, Thibault Sixt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?